Viewing Study NCT02944357


Ignite Creation Date: 2025-12-24 @ 6:47 PM
Ignite Modification Date: 2026-02-25 @ 9:40 PM
Study NCT ID: NCT02944357
Status: WITHDRAWN
Last Update Posted: 2017-11-17
First Post: 2016-10-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery
Sponsor: Mayo Clinic
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Infiltrating Bladder Urothelial Carcinoma View
None Stage II Bladder Urothelial Carcinoma View
None Stage III Bladder Urothelial Carcinoma View
None Stage IV Bladder Urothelial Carcinoma View
Keywords: